Targeting of Immune Cells by Dual TLR2/7 Ligands Suppresses Features of Allergic Th2 Immune Responses in Mice.
Jonathan LaiñoAndrea WangorschFrank BlancoSonja WolfheimerMaren KrauseAdam FlaczykTobias-Maximilian MöllerMindy TsaiStephen GalliStefan ViethsMasako TodaStephan ScheurerStefan SchülkePublished in: Journal of immunology research (2017)
Based on beneficial immune-modulating properties, CL413 and CL531 may have utility as potential adjuvants for allergy treatment.